Pluto Bioinformatics

GSE48843: RNA-Seq analysis of primary AML specimens exposed to AhR modulating agents

Bulk RNA sequencing

The goal of the study was to identify genes that are directly or indirectly coregulated by the AhR pathway in primary human AML cells. Patient AML cells were treated for 16 hours with the two indirubin derivatives 6-bromoindirubin-3'oxime (BIO), 1-Methyl-6-bromoindirubin-3'oxime (MeBIO), the AHR-antagonist SR1 (StemReginin1), combinations of BIO+SR1 and MeBIO+SR1 or DMSO alone at indicated concentrations prior to RNA extraction for sequencing. SOURCE: Guy Sauvageau Institute for Research in Immunology and Cancer

View this experiment on Pluto Bioinformatics